BRCC BRC Inc. Insider Trading

Evan Hafer sold 2,000,000 shares of BRCC at $1.49 on 2026-06-01 for $3.0M; retains 28,142,374 common units through holding company.

Founder Evan Hafer sold 2,000,000 shares at $1.49 on 2026-06-01, reducing his direct non-derivative holdings to zero, though he retains 28,142,374 common units through EKNRH Holdings LLC. The sale occurs when the stock is down 28.6% from its 52-week high of $2.10 but has rallied 37.6% over the prior 30 days and 96.8% over 90 days, indicating a spike in momentum into the transaction. His same-ticker history at BRCC shows 5 prior trades all well-timed at the 90-day mark (4 prior sales with negative 90d returns and 1 buy with positive 90d return), though the company remains unprofitable with full-year net income negative and annual revenue growth of just +1.7%. The timing of this trade relative to recent price appreciation and his track record of well-timed exits at this ticker warrants observation of whether the 90-day post-transaction period repeats his pattern.

Director Taslitz buys 300,000 BRCC shares for $223,500 (avg $0.74), doubling holdings; stock down 62.4% YTD.

Steven Taslitz, a director at BRC Inc., executed 2 separate purchases totaling 300,000 shares for $223,500.00, increasing his position from 301,184 to 601,184 shares. At a blended average price of $0.74, the transaction occurred when the stock trades at $0.89 current price, down -62.4% from its 52-week high of $2.37 and down -28.2% over the past 90 days despite a +7.8% 30-day rebound. Taslitz's prior 4 purchases at BRCC show a 0 of 4 record of favorable 90-day timing outcomes (each prior buy was followed by further declines ranging from -1.9% to -43.7%), and his cross-ticker track record shows a 0.00% 90d win rate. The company reported net income of $-486,000.00 on revenue of $100,712,000.00, with annual growth of +1.7% and unprofitable operations over its most recent full fiscal year. This large open-market accumulation coincides with weak fundamentals and depressed valuation, but the director's purchase history at this ticker offers little evidence of successful timing acumen.

Director Taslitz buys 100,000 shares of BRCC at $1.29 as stock down -62.3% from 52-week high

Taslitz Steven, a director at BRC Inc., purchased 100,000 shares at $1.29 on 2025-11-17, bringing his holdings to 1,886,203 shares and representing a 5.6% increase in his position. The purchase occurs while BRCC trades at $1.21, down 62.3% from its 52-week high of $3.21 and down 14.2% over the prior 30 days. Critically, the company reported a net loss of $486,000.00 over the latest quarter and has posted negative full-year net income, with annual revenue declining 1.0% year-over-year. Taslitz's cross-ticker track record shows a 0.00% win rate at the 90-day mark and his prior BRCC trades exhibit poor timing outcomes: his buy on 2025-08-08 returned -20.0% at 90 days, and his buy on 2025-08-07 returned -1.9%, with 0 of 2 prior BRCC purchases well-timed at the 90-day mark. The combination of deteriorating fundamentals, sustained price decline, and this insider's historical pattern of ill-timed purchases at this ticker suggests elevated downside risk.

Director Taslitz Steven purchases 100,000 shares of BRCC at $1.28; stock down -59.8% from 52-week high amid unprofitable operations.

Taslitz Steven (Director) acquired 100,000 shares of BRCC at $1.28 on 2025-11-12, expanding his holdings from 351.2K to 451.2K shares (+28.5%). The purchase occurs while the stock trades 59.8% below its 52-week high of $3.21 and the company is unprofitable with net income of -$486.0K on quarterly revenue of $100.7M. His prior two trades at BRCC (both purchases in August 2025) showed mixed outcomes: the 2025-08-07 buy returned +16.4% over 30 days but -1.9% over 90 days; the 2025-08-08 buy returned +0.3% over 30 days but -20.0% over 90 days, with a 0.00% 90-day win rate across those prior BRCC trades. His cross-ticker track record (2 prior buys across all tickers) shows an average 30-day return of +8.3% but average 90-day return of -11.0% with a 0.00% 90-day win rate, indicating no success in timing entries well on a multi-month horizon.

Director Taslitz Steven purchased 200,000 shares in 2 transactions (Aug 7-8) at blended avg $1.42; holdings increased 132.3% to 351.2K shares amid ongoing losses.

Taslitz Steven, a director at BRC Inc., executed 2 separate purchases totaling 200,000 shares for $284,000.00 at prices of $1.32 and $1.52 on consecutive days (August 7-8, 2025), substantially increasing his shareholding from 151.2K to 351.2K shares. The company is currently unprofitable with a net income of $-5.3M in the latest quarter and negative full-year results, while trading 73.6% below its 52-week high of $5.42. This accumulation by a director during a period of operational losses and depressed valuation relative to recent trading range merits examination of whether the purchase reflects forward confidence or responds to specific operational developments not evident in the raw financial metrics.

Director Welling Glenn W. buys 400,000 BRCC shares at $1.25; cluster of 4 insider buys in 14 days amid unprofitable quarter.

Glenn W. Welling, a director, purchased 400,000 shares of BRC Inc. at $1.25 on 2025-07-18, raising his holdings to 13,935,560 shares. The transaction occurs during a period of coordinated insider activity: 3 other insiders also bought within the past 14 days, suggesting aligned conviction at current valuations. However, the fundamental backdrop is material: the company posted a net loss of $-2,888,000.00 in its latest quarter, annual revenue growth is negative at -1.0%, and the company remained unprofitable over its most recent full fiscal year. At his prior BRCC transactions, Welling's timing has been mixed: 2 of his 3 prior buys at this ticker yielded positive 90-day returns (+27.5% and +19.1%), but his most recent September 2024 buy resulted in a 90-day decline of -1.9%. The stock is currently trading at $1.91, down -67.5% from its 52-week high of $5.87, which provides context for the timing of this accumulation relative to depressed levels.

Director Kathryn P Dickson buys 16,000 shares of BRCC at $1.25; cluster pattern with 3 other insiders in past 14 days

Dickson, a director, purchased 16,000 shares at $1.25 on 2025-07-18, increasing her holdings by 4.3% to 392,045 shares. Her prior trades at BRCC show strong 90-day outcomes (13.3% and 32.1%), with 2 of 2 buys well-timed at the 90-day mark. The broader cluster context—3 other insiders buying within the past 14 days—suggests coordinated or synchronized conviction across the insider group. However, this occurs against a backdrop of negative fundamentals: the company posted a $-2.9M net income on $90.0M revenue and is unprofitable on a full-year basis, with annual revenue growth of -1.0%. The stock is trading at $1.63, down -72.7% from its 52-week high of $5.98. The clustering of insider buys at depressed valuations warrants scrutiny given the unprofitable operating performance.

Director Hafer Evan buys 80,000 shares of BRCC at $1.25; cluster buy pattern with 3 other insiders in 14 days

Director Evan Hafer purchased 80,000 shares at $1.25 on 2025-07-18, representing his first accumulation at BRCC (0 prior holdings). This buy occurs within a cluster: 3 other insiders also bought within the past 14 days, suggesting coordinated or consensus-driven action rather than isolated conviction. The timing context is mixed: the stock currently trades at $1.63 (+14.0% in 30 days) but remains -72.7% from its 52-week high of $5.98, indicating a substantial decline from recent peaks. Fundamentally, BRCC faces headwinds—annual revenue growth is -1.0%, the latest quarter showed a net loss of $-2.9M on revenue of $90.0M, and the company was unprofitable over its most recent full fiscal year. Hafer's cross-ticker track record shows 4 prior sells with a 90-day well-timed rate of 100.00%, but his BRCC-specific history (4 prior sells) is limited; both same-ticker sells showed negative 90-day returns post-sale, consistent with disciplined exit timing. The cluster buy pattern warrants attention as a potential signal of management-level assessment that the stock has declined sufficiently, though the unprofitable fundamentals and negative revenue trajectory remain material headwinds.

Director Kadenacy Stephen M purchased 80,000 shares of BRCC at $1.25 (total $100,000) on 2025-07-18; cluster buy pattern emerges as 3 other insiders bought within 14 days.

Kadenacy Stephen M, a director of BRCC, acquired 80,000 shares at $1.25, increasing his holdings from 988,482 to 1,068,482 shares—an 8.1% increase. This purchase coincides with a broader cluster pattern in which 3 other insiders also bought within the past 14 days, suggesting coordinated directional confidence at this price level. The timing is notable: the stock is trading at $1.63 (currently +14.0% over 30 days) but remains 72.7% below its 52-week high of $5.98, and the company is unprofitable with negative net income of $-2.9M against quarterly revenue of $90.0M. The cluster buying activity by multiple insiders at depressed valuations relative to recent highs, combined with the company's ongoing unprofitability, warrants close attention to whether insiders are positioning ahead of operational improvements or restructuring.

Director Evan Hafer sells 1,000,000 shares at $3.17 (3 transactions, $3.17M), reducing holdings to 0

Evan Hafer, a Director at BRC Inc., executed 3 separate sales totaling 1,000,000 shares for $3,170,000.00 on 2024-09-13 at $3.17 per share, reducing his holdings to zero shares from 1,000,000 shares pre-transaction. The stock is currently trading at $3.67, which is 46.0% below its 52-week high of $6.80, and has declined 41.1% over the past 90 days. This is the insider's second transaction at BRCC following a sale on 2024-09-11, demonstrating consecutive liquidation activity at this ticker. The company reported quarterly revenue of $89,017,000.00 but posted a net loss of $482,000.00 and has not achieved profitability on a full-year basis, setting a context of operational headwinds despite 31.3% annual revenue growth. The conversion nature of this transaction warrants review of derivative positions shown in Form 4 Table II to assess whether the director maintains beneficial ownership through other securities.